nodes	percent_of_prediction	percent_of_DWPC	metapath
Imipramine—CYP2D6—Lomustine—brain cancer	0.0739	0.187	CbGbCtD
Imipramine—CYP1A2—Carmustine—brain cancer	0.0731	0.185	CbGbCtD
Imipramine—CYP2D6—Hydroxyurea—brain cancer	0.056	0.142	CbGbCtD
Imipramine—CYP3A4—Temozolomide—brain cancer	0.0552	0.14	CbGbCtD
Imipramine—CYP3A4—Lomustine—brain cancer	0.047	0.119	CbGbCtD
Imipramine—CYP2E1—Etoposide—brain cancer	0.0375	0.095	CbGbCtD
Imipramine—CYP1A2—Etoposide—brain cancer	0.0217	0.0549	CbGbCtD
Imipramine—ABCB1—Etoposide—brain cancer	0.0189	0.048	CbGbCtD
Imipramine—HTR2C—choroid plexus—brain cancer	0.0122	0.0542	CbGeAlD
Imipramine—CYP3A4—Etoposide—brain cancer	0.0113	0.0288	CbGbCtD
Imipramine—HTR2A—choroid plexus—brain cancer	0.00613	0.0272	CbGeAlD
Imipramine—HRH1—nose—brain cancer	0.00473	0.021	CbGeAlD
Imipramine—HTR7—vein—brain cancer	0.00449	0.0199	CbGeAlD
Imipramine—KCND2—hindbrain—brain cancer	0.00393	0.0174	CbGeAlD
Imipramine—HTR6—ganglion—brain cancer	0.00385	0.0171	CbGeAlD
Imipramine—SLC6A3—telencephalic ventricle—brain cancer	0.0037	0.0164	CbGeAlD
Imipramine—HTR2C—telencephalic ventricle—brain cancer	0.00358	0.0159	CbGeAlD
Imipramine—HTR7—cranial nerve—brain cancer	0.00354	0.0157	CbGeAlD
Imipramine—HTR7—pons—brain cancer	0.0035	0.0155	CbGeAlD
Imipramine—KCND3—hindbrain—brain cancer	0.00343	0.0152	CbGeAlD
Imipramine—HTR2A—trigeminal nerve—brain cancer	0.0031	0.0137	CbGeAlD
Imipramine—HTR2A—cerebellar cortex—brain cancer	0.00309	0.0137	CbGeAlD
Imipramine—HTR1A—telencephalic ventricle—brain cancer	0.00301	0.0134	CbGeAlD
Imipramine—HTR7—telencephalic ventricle—brain cancer	0.00288	0.0128	CbGeAlD
Imipramine—HTR2A—vein—brain cancer	0.0028	0.0124	CbGeAlD
Imipramine—DRD2—telencephalic ventricle—brain cancer	0.00272	0.0121	CbGeAlD
Imipramine—SLC6A3—ganglion—brain cancer	0.0023	0.0102	CbGeAlD
Imipramine—SLC22A1—ganglion—brain cancer	0.00227	0.0101	CbGeAlD
Imipramine—KCND2—brainstem—brain cancer	0.00225	0.01	CbGeAlD
Imipramine—HTR2C—ganglion—brain cancer	0.00223	0.00988	CbGeAlD
Imipramine—HTR2A—cranial nerve—brain cancer	0.00221	0.00979	CbGeAlD
Imipramine—HTR2A—pons—brain cancer	0.00218	0.00967	CbGeAlD
Imipramine—SLC6A4—ganglion—brain cancer	0.00211	0.00936	CbGeAlD
Imipramine—KCND2—telencephalon—brain cancer	0.002	0.00887	CbGeAlD
Imipramine—KCND3—brainstem—brain cancer	0.00197	0.00872	CbGeAlD
Imipramine—HTR1A—ganglion—brain cancer	0.00187	0.00831	CbGeAlD
Imipramine—SLC6A2—ganglion—brain cancer	0.00186	0.00824	CbGeAlD
Imipramine—HTR2A—telencephalic ventricle—brain cancer	0.0018	0.00796	CbGeAlD
Imipramine—HTR7—ganglion—brain cancer	0.00179	0.00795	CbGeAlD
Imipramine—SLC6A3—hindbrain—brain cancer	0.00175	0.00775	CbGeAlD
Imipramine—KCND3—telencephalon—brain cancer	0.00174	0.00774	CbGeAlD
Imipramine—DRD2—ganglion—brain cancer	0.00169	0.00751	CbGeAlD
Imipramine—KCND2—pituitary gland—brain cancer	0.00163	0.00722	CbGeAlD
Imipramine—SLC6A4—hindbrain—brain cancer	0.0016	0.0071	CbGeAlD
Imipramine—KCND2—medulla oblongata—brain cancer	0.00157	0.00697	CbGeAlD
Imipramine—HTR2A—pineal body—brain cancer	0.00156	0.00691	CbGeAlD
Imipramine—HTR7—endothelium—brain cancer	0.00155	0.00685	CbGeAlD
Imipramine—HTR6—telencephalon—brain cancer	0.00149	0.00659	CbGeAlD
Imipramine—KCND2—midbrain—brain cancer	0.00144	0.00637	CbGeAlD
Imipramine—HTR7—blood vessel—brain cancer	0.00142	0.00632	CbGeAlD
Imipramine—HTR1A—hindbrain—brain cancer	0.00142	0.00631	CbGeAlD
Imipramine—KCND2—spinal cord—brain cancer	0.0014	0.00622	CbGeAlD
Imipramine—HTR7—hindbrain—brain cancer	0.00136	0.00603	CbGeAlD
Imipramine—ADRA1A—hindbrain—brain cancer	0.00131	0.00581	CbGeAlD
Imipramine—DRD2—hindbrain—brain cancer	0.00128	0.0057	CbGeAlD
Imipramine—KCND3—midbrain—brain cancer	0.00125	0.00555	CbGeAlD
Imipramine—KCND2—head—brain cancer	0.00125	0.00552	CbGeAlD
Imipramine—ADRA1D—telencephalon—brain cancer	0.00116	0.00515	CbGeAlD
Imipramine—KCND2—central nervous system—brain cancer	0.00114	0.00504	CbGeAlD
Imipramine—HTR2A—ganglion—brain cancer	0.00112	0.00496	CbGeAlD
Imipramine—KCND2—cerebellum—brain cancer	0.00111	0.00493	CbGeAlD
Imipramine—KCND3—head—brain cancer	0.00109	0.00482	CbGeAlD
Imipramine—CHRM4—head—brain cancer	0.00103	0.00459	CbGeAlD
Imipramine—SLC6A3—brainstem—brain cancer	0.001	0.00444	CbGeAlD
Imipramine—CYP2C18—endocrine gland—brain cancer	0.001	0.00444	CbGeAlD
Imipramine—KCND3—central nervous system—brain cancer	0.000991	0.0044	CbGeAlD
Imipramine—Ataxia—Carmustine—brain cancer	0.000985	0.004	CcSEcCtD
Imipramine—Nervousness—Procarbazine—brain cancer	0.00098	0.00398	CcSEcCtD
Imipramine—Neuropathy peripheral—Hydroxyurea—brain cancer	0.000979	0.00398	CcSEcCtD
Imipramine—Stomatitis—Hydroxyurea—brain cancer	0.000974	0.00396	CcSEcCtD
Imipramine—KCND3—cerebellum—brain cancer	0.000969	0.0043	CbGeAlD
Imipramine—HTR2C—brainstem—brain cancer	0.000968	0.00429	CbGeAlD
Imipramine—Liver function test abnormal—Carmustine—brain cancer	0.000967	0.00393	CcSEcCtD
Imipramine—HTR2A—endothelium—brain cancer	0.000963	0.00427	CbGeAlD
Imipramine—Mood swings—Temozolomide—brain cancer	0.000959	0.0039	CcSEcCtD
Imipramine—CYP3A7—endocrine gland—brain cancer	0.000953	0.00423	CbGeAlD
Imipramine—Ataxia—Temozolomide—brain cancer	0.000952	0.00387	CcSEcCtD
Imipramine—Tremor—Procarbazine—brain cancer	0.000945	0.00384	CcSEcCtD
Imipramine—Hepatobiliary disease—Hydroxyurea—brain cancer	0.000945	0.00384	CcSEcCtD
Imipramine—CHRM4—central nervous system—brain cancer	0.000944	0.00419	CbGeAlD
Imipramine—HTR6—head—brain cancer	0.000926	0.00411	CbGeAlD
Imipramine—SLC6A4—brainstem—brain cancer	0.000918	0.00407	CbGeAlD
Imipramine—Breast disorder—Temozolomide—brain cancer	0.000915	0.00372	CcSEcCtD
Imipramine—Syncope—Procarbazine—brain cancer	0.000905	0.00368	CcSEcCtD
Imipramine—Leukopenia—Procarbazine—brain cancer	0.000903	0.00367	CcSEcCtD
Imipramine—KCND2—brain—brain cancer	0.000903	0.004	CbGeAlD
Imipramine—Cardiac failure congestive—Etoposide—brain cancer	0.000894	0.00363	CcSEcCtD
Imipramine—Hallucination—Hydroxyurea—brain cancer	0.000892	0.00363	CcSEcCtD
Imipramine—CHRM2—telencephalon—brain cancer	0.000892	0.00395	CbGeAlD
Imipramine—SLC6A3—telencephalon—brain cancer	0.000889	0.00394	CbGeAlD
Imipramine—HTR2A—blood vessel—brain cancer	0.000889	0.00394	CbGeAlD
Imipramine—Loss of consciousness—Procarbazine—brain cancer	0.000887	0.0036	CcSEcCtD
Imipramine—SLC22A1—telencephalon—brain cancer	0.000876	0.00388	CbGeAlD
Imipramine—Convulsion—Procarbazine—brain cancer	0.000874	0.00355	CcSEcCtD
Imipramine—Hypertension—Procarbazine—brain cancer	0.000871	0.00354	CcSEcCtD
Imipramine—Pancytopenia—Carmustine—brain cancer	0.00086	0.0035	CcSEcCtD
Imipramine—HTR2C—telencephalon—brain cancer	0.000859	0.00381	CbGeAlD
Imipramine—Anxiety—Procarbazine—brain cancer	0.000856	0.00348	CcSEcCtD
Imipramine—HTR2A—hindbrain—brain cancer	0.000847	0.00376	CbGeAlD
Imipramine—HTR6—central nervous system—brain cancer	0.000845	0.00375	CbGeAlD
Imipramine—Dry mouth—Procarbazine—brain cancer	0.00084	0.00341	CcSEcCtD
Imipramine—Pancytopenia—Temozolomide—brain cancer	0.000831	0.00338	CcSEcCtD
Imipramine—Cardiac failure—Etoposide—brain cancer	0.00083	0.00337	CcSEcCtD
Imipramine—Confusional state—Procarbazine—brain cancer	0.00083	0.00337	CcSEcCtD
Imipramine—Vomiting—Lomustine—brain cancer	0.000824	0.00335	CcSEcCtD
Imipramine—Oedema—Procarbazine—brain cancer	0.000823	0.00335	CcSEcCtD
Imipramine—Infection—Procarbazine—brain cancer	0.000818	0.00332	CcSEcCtD
Imipramine—HTR1A—brainstem—brain cancer	0.000815	0.00361	CbGeAlD
Imipramine—SLC6A4—telencephalon—brain cancer	0.000815	0.00361	CbGeAlD
Imipramine—Angiopathy—Hydroxyurea—brain cancer	0.000814	0.00331	CcSEcCtD
Imipramine—CHRM1—telencephalon—brain cancer	0.000811	0.0036	CbGeAlD
Imipramine—Shock—Procarbazine—brain cancer	0.00081	0.00329	CcSEcCtD
Imipramine—CHRM5—head—brain cancer	0.000809	0.00359	CbGeAlD
Imipramine—Pollakiuria—Temozolomide—brain cancer	0.000809	0.00329	CcSEcCtD
Imipramine—SLC6A2—brainstem—brain cancer	0.000808	0.00358	CbGeAlD
Imipramine—Erectile dysfunction—Temozolomide—brain cancer	0.000806	0.00328	CcSEcCtD
Imipramine—Thrombocytopenia—Procarbazine—brain cancer	0.000806	0.00328	CcSEcCtD
Imipramine—Tachycardia—Procarbazine—brain cancer	0.000803	0.00327	CcSEcCtD
Imipramine—Photosensitivity reaction—Temozolomide—brain cancer	0.000799	0.00325	CcSEcCtD
Imipramine—Weight increased—Temozolomide—brain cancer	0.000797	0.00324	CcSEcCtD
Imipramine—Hyperhidrosis—Procarbazine—brain cancer	0.000796	0.00323	CcSEcCtD
Imipramine—Alopecia—Hydroxyurea—brain cancer	0.000792	0.00322	CcSEcCtD
Imipramine—Weight decreased—Temozolomide—brain cancer	0.000792	0.00322	CcSEcCtD
Imipramine—Neuropathy peripheral—Carmustine—brain cancer	0.000792	0.00322	CcSEcCtD
Imipramine—Stomatitis—Carmustine—brain cancer	0.000787	0.0032	CcSEcCtD
Imipramine—KCND3—brain—brain cancer	0.000787	0.00349	CbGeAlD
Imipramine—Anorexia—Procarbazine—brain cancer	0.000785	0.00319	CcSEcCtD
Imipramine—Infestation NOS—Temozolomide—brain cancer	0.00078	0.00317	CcSEcCtD
Imipramine—Infestation—Temozolomide—brain cancer	0.00078	0.00317	CcSEcCtD
Imipramine—HTR7—brainstem—brain cancer	0.000779	0.00345	CbGeAlD
Imipramine—CYP2D6—hindbrain—brain cancer	0.000772	0.00342	CbGeAlD
Imipramine—Nausea—Lomustine—brain cancer	0.00077	0.00313	CcSEcCtD
Imipramine—Neuropathy peripheral—Temozolomide—brain cancer	0.000765	0.00311	CcSEcCtD
Imipramine—Stomatitis—Temozolomide—brain cancer	0.000761	0.00309	CcSEcCtD
Imipramine—ADRA1A—brainstem—brain cancer	0.000751	0.00333	CbGeAlD
Imipramine—CHRM4—brain—brain cancer	0.00075	0.00333	CbGeAlD
Imipramine—SLC22A4—pituitary gland—brain cancer	0.000749	0.00332	CbGeAlD
Imipramine—Insomnia—Procarbazine—brain cancer	0.000745	0.00303	CcSEcCtD
Imipramine—Paraesthesia—Procarbazine—brain cancer	0.000739	0.003	CcSEcCtD
Imipramine—ADRA1B—head—brain cancer	0.000739	0.00328	CbGeAlD
Imipramine—CHRM5—central nervous system—brain cancer	0.000738	0.00327	CbGeAlD
Imipramine—Hepatobiliary disease—Temozolomide—brain cancer	0.000738	0.003	CcSEcCtD
Imipramine—DRD2—brainstem—brain cancer	0.000736	0.00327	CbGeAlD
Imipramine—ADRA1D—endocrine gland—brain cancer	0.000732	0.00325	CbGeAlD
Imipramine—Somnolence—Procarbazine—brain cancer	0.000732	0.00297	CcSEcCtD
Imipramine—CHRM3—telencephalon—brain cancer	0.000726	0.00322	CbGeAlD
Imipramine—Ill-defined disorder—Hydroxyurea—brain cancer	0.000724	0.00294	CcSEcCtD
Imipramine—HTR1A—telencephalon—brain cancer	0.000723	0.00321	CbGeAlD
Imipramine—ADRA1D—head—brain cancer	0.000723	0.00321	CbGeAlD
Imipramine—Hypoaesthesia—Carmustine—brain cancer	0.000721	0.00293	CcSEcCtD
Imipramine—Hallucination—Carmustine—brain cancer	0.000721	0.00293	CcSEcCtD
Imipramine—SLC6A2—telencephalon—brain cancer	0.000717	0.00318	CbGeAlD
Imipramine—Decreased appetite—Procarbazine—brain cancer	0.000716	0.00291	CcSEcCtD
Imipramine—Fatigue—Procarbazine—brain cancer	0.00071	0.00288	CcSEcCtD
Imipramine—Malaise—Hydroxyurea—brain cancer	0.000704	0.00286	CcSEcCtD
Imipramine—Constipation—Procarbazine—brain cancer	0.000704	0.00286	CcSEcCtD
Imipramine—Hepatitis—Temozolomide—brain cancer	0.000701	0.00285	CcSEcCtD
Imipramine—Leukopenia—Hydroxyurea—brain cancer	0.000699	0.00284	CcSEcCtD
Imipramine—SLC22A3—gonad—brain cancer	0.000698	0.0031	CbGeAlD
Imipramine—Hallucination—Temozolomide—brain cancer	0.000697	0.00283	CcSEcCtD
Imipramine—Hypoaesthesia—Temozolomide—brain cancer	0.000697	0.00283	CcSEcCtD
Imipramine—Urinary tract disorder—Temozolomide—brain cancer	0.000692	0.00281	CcSEcCtD
Imipramine—HTR7—telencephalon—brain cancer	0.000691	0.00307	CbGeAlD
Imipramine—Urethral disorder—Temozolomide—brain cancer	0.000687	0.00279	CcSEcCtD
Imipramine—Feeling abnormal—Procarbazine—brain cancer	0.000678	0.00276	CcSEcCtD
Imipramine—Eye disorder—Carmustine—brain cancer	0.000677	0.00275	CcSEcCtD
Imipramine—Convulsion—Hydroxyurea—brain cancer	0.000676	0.00275	CcSEcCtD
Imipramine—HTR2C—medulla oblongata—brain cancer	0.000675	0.00299	CbGeAlD
Imipramine—ADRA1B—central nervous system—brain cancer	0.000675	0.00299	CbGeAlD
Imipramine—Gastrointestinal pain—Procarbazine—brain cancer	0.000673	0.00274	CcSEcCtD
Imipramine—Flushing—Carmustine—brain cancer	0.000673	0.00273	CcSEcCtD
Imipramine—HTR6—brain—brain cancer	0.000671	0.00298	CbGeAlD
Imipramine—ORM1—spinal cord—brain cancer	0.00067	0.00297	CbGeAlD
Imipramine—ADRA1A—telencephalon—brain cancer	0.000667	0.00296	CbGeAlD
Imipramine—Pancytopenia—Etoposide—brain cancer	0.000665	0.0027	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00066	0.00268	CcSEcCtD
Imipramine—ADRA1D—central nervous system—brain cancer	0.00066	0.00293	CbGeAlD
Imipramine—Discomfort—Hydroxyurea—brain cancer	0.000657	0.00267	CcSEcCtD
Imipramine—Eye disorder—Temozolomide—brain cancer	0.000655	0.00266	CcSEcCtD
Imipramine—Urticaria—Procarbazine—brain cancer	0.000654	0.00266	CcSEcCtD
Imipramine—DRD2—telencephalon—brain cancer	0.000654	0.0029	CbGeAlD
Imipramine—Tinnitus—Temozolomide—brain cancer	0.000653	0.00265	CcSEcCtD
Imipramine—Abdominal pain—Procarbazine—brain cancer	0.000651	0.00264	CcSEcCtD
Imipramine—Body temperature increased—Procarbazine—brain cancer	0.000651	0.00264	CcSEcCtD
Imipramine—Cardiac disorder—Temozolomide—brain cancer	0.00065	0.00264	CcSEcCtD
Imipramine—Flushing—Temozolomide—brain cancer	0.00065	0.00264	CcSEcCtD
Imipramine—Arrhythmia—Carmustine—brain cancer	0.000648	0.00263	CcSEcCtD
Imipramine—SLC22A4—spinal cord—brain cancer	0.000644	0.00286	CbGeAlD
Imipramine—KCNH2—telencephalon—brain cancer	0.000644	0.00286	CbGeAlD
Imipramine—Alopecia—Carmustine—brain cancer	0.000641	0.0026	CcSEcCtD
Imipramine—SLC6A3—midbrain—brain cancer	0.000638	0.00283	CbGeAlD
Imipramine—Oedema—Hydroxyurea—brain cancer	0.000637	0.00259	CcSEcCtD
Imipramine—Angiopathy—Temozolomide—brain cancer	0.000636	0.00258	CcSEcCtD
Imipramine—Carbamazepine—CYP2C9—brain cancer	0.000636	0.165	CrCbGaD
Imipramine—Mental disorder—Carmustine—brain cancer	0.000635	0.00258	CcSEcCtD
Imipramine—Infection—Hydroxyurea—brain cancer	0.000633	0.00257	CcSEcCtD
Imipramine—Immune system disorder—Temozolomide—brain cancer	0.000633	0.00257	CcSEcCtD
Imipramine—Mediastinal disorder—Temozolomide—brain cancer	0.000631	0.00257	CcSEcCtD
Imipramine—Malnutrition—Carmustine—brain cancer	0.000631	0.00256	CcSEcCtD
Imipramine—Nervous system disorder—Hydroxyurea—brain cancer	0.000625	0.00254	CcSEcCtD
Imipramine—Infestation—Etoposide—brain cancer	0.000624	0.00254	CcSEcCtD
Imipramine—Infestation NOS—Etoposide—brain cancer	0.000624	0.00254	CcSEcCtD
Imipramine—Thrombocytopenia—Hydroxyurea—brain cancer	0.000624	0.00254	CcSEcCtD
Imipramine—SLC6A3—spinal cord—brain cancer	0.000623	0.00276	CbGeAlD
Imipramine—Alopecia—Temozolomide—brain cancer	0.000619	0.00252	CcSEcCtD
Imipramine—Skin disorder—Hydroxyurea—brain cancer	0.000619	0.00251	CcSEcCtD
Imipramine—HTR2C—midbrain—brain cancer	0.000617	0.00274	CbGeAlD
Imipramine—Acute coronary syndrome—Etoposide—brain cancer	0.000616	0.0025	CcSEcCtD
Imipramine—Mental disorder—Temozolomide—brain cancer	0.000614	0.00249	CcSEcCtD
Imipramine—Myocardial infarction—Etoposide—brain cancer	0.000612	0.00249	CcSEcCtD
Imipramine—Neuropathy peripheral—Etoposide—brain cancer	0.000612	0.00249	CcSEcCtD
Imipramine—Malnutrition—Temozolomide—brain cancer	0.00061	0.00248	CcSEcCtD
Imipramine—Jaundice—Etoposide—brain cancer	0.000609	0.00247	CcSEcCtD
Imipramine—Stomatitis—Etoposide—brain cancer	0.000609	0.00247	CcSEcCtD
Imipramine—Anorexia—Hydroxyurea—brain cancer	0.000607	0.00247	CcSEcCtD
Imipramine—ORM1—endocrine gland—brain cancer	0.000603	0.00267	CbGeAlD
Imipramine—HTR2C—spinal cord—brain cancer	0.000602	0.00267	CbGeAlD
Imipramine—SLC6A2—gonad—brain cancer	0.000599	0.00265	CbGeAlD
Imipramine—Dysgeusia—Temozolomide—brain cancer	0.000597	0.00243	CcSEcCtD
Imipramine—Vision blurred—Carmustine—brain cancer	0.000595	0.00242	CcSEcCtD
Imipramine—Tremor—Carmustine—brain cancer	0.000591	0.0024	CcSEcCtD
Imipramine—Asthenia—Procarbazine—brain cancer	0.000591	0.0024	CcSEcCtD
Imipramine—Hepatobiliary disease—Etoposide—brain cancer	0.000591	0.0024	CcSEcCtD
Imipramine—CHRM5—brain—brain cancer	0.000586	0.0026	CbGeAlD
Imipramine—SLC6A4—midbrain—brain cancer	0.000585	0.00259	CbGeAlD
Imipramine—Agranulocytosis—Etoposide—brain cancer	0.000583	0.00237	CcSEcCtD
Imipramine—Pruritus—Procarbazine—brain cancer	0.000582	0.00237	CcSEcCtD
Imipramine—ABCB1—blood vessel—brain cancer	0.000582	0.00258	CbGeAlD
Imipramine—Agitation—Carmustine—brain cancer	0.00058	0.00236	CcSEcCtD
Imipramine—HTR7—gonad—brain cancer	0.000577	0.00256	CbGeAlD
Imipramine—Vision blurred—Temozolomide—brain cancer	0.000575	0.00234	CcSEcCtD
Imipramine—Tremor—Temozolomide—brain cancer	0.000571	0.00232	CcSEcCtD
Imipramine—SLC6A4—spinal cord—brain cancer	0.000571	0.00253	CbGeAlD
Imipramine—Somnolence—Hydroxyurea—brain cancer	0.000566	0.0023	CcSEcCtD
Imipramine—Ill-defined disorder—Temozolomide—brain cancer	0.000566	0.0023	CcSEcCtD
Imipramine—Leukopenia—Carmustine—brain cancer	0.000565	0.0023	CcSEcCtD
Imipramine—SLC6A2—medulla oblongata—brain cancer	0.000563	0.0025	CbGeAlD
Imipramine—Diarrhoea—Procarbazine—brain cancer	0.000563	0.00229	CcSEcCtD
Imipramine—CHRM2—endocrine gland—brain cancer	0.000562	0.00249	CbGeAlD
Imipramine—Dyspepsia—Hydroxyurea—brain cancer	0.000561	0.00228	CcSEcCtD
Imipramine—Agitation—Temozolomide—brain cancer	0.00056	0.00228	CcSEcCtD
Imipramine—Hypoaesthesia—Etoposide—brain cancer	0.000558	0.00227	CcSEcCtD
Imipramine—CHRM2—head—brain cancer	0.000555	0.00246	CbGeAlD
Imipramine—Decreased appetite—Hydroxyurea—brain cancer	0.000554	0.00225	CcSEcCtD
Imipramine—Urinary tract disorder—Etoposide—brain cancer	0.000554	0.00225	CcSEcCtD
Imipramine—SLC6A3—head—brain cancer	0.000554	0.00245	CbGeAlD
Imipramine—SLC22A1—endocrine gland—brain cancer	0.000552	0.00245	CbGeAlD
Imipramine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00055	0.00224	CcSEcCtD
Imipramine—Malaise—Temozolomide—brain cancer	0.00055	0.00224	CcSEcCtD
Imipramine—Urethral disorder—Etoposide—brain cancer	0.00055	0.00223	CcSEcCtD
Imipramine—Fatigue—Hydroxyurea—brain cancer	0.000549	0.00223	CcSEcCtD
Imipramine—Convulsion—Carmustine—brain cancer	0.000547	0.00222	CcSEcCtD
Imipramine—Leukopenia—Temozolomide—brain cancer	0.000546	0.00222	CcSEcCtD
Imipramine—SLC22A1—head—brain cancer	0.000545	0.00242	CbGeAlD
Imipramine—Hypertension—Carmustine—brain cancer	0.000545	0.00221	CcSEcCtD
Imipramine—Constipation—Hydroxyurea—brain cancer	0.000545	0.00221	CcSEcCtD
Imipramine—Dizziness—Procarbazine—brain cancer	0.000544	0.00221	CcSEcCtD
Imipramine—ORM1—central nervous system—brain cancer	0.000543	0.00241	CbGeAlD
Imipramine—HTR7—medulla oblongata—brain cancer	0.000543	0.00241	CbGeAlD
Imipramine—Palpitations—Temozolomide—brain cancer	0.000539	0.00219	CcSEcCtD
Imipramine—ADRA1B—brain—brain cancer	0.000536	0.00237	CbGeAlD
Imipramine—Anxiety—Carmustine—brain cancer	0.000535	0.00218	CcSEcCtD
Imipramine—HTR2C—head—brain cancer	0.000535	0.00237	CbGeAlD
Imipramine—DRD2—pituitary gland—brain cancer	0.000532	0.00236	CbGeAlD
Imipramine—Convulsion—Temozolomide—brain cancer	0.000528	0.00215	CcSEcCtD
Imipramine—SLC22A3—endocrine gland—brain cancer	0.000528	0.00234	CbGeAlD
Imipramine—Hypertension—Temozolomide—brain cancer	0.000527	0.00214	CcSEcCtD
Imipramine—Feeling abnormal—Hydroxyurea—brain cancer	0.000525	0.00213	CcSEcCtD
Imipramine—KCNH2—pituitary gland—brain cancer	0.000524	0.00233	CbGeAlD
Imipramine—Eye disorder—Etoposide—brain cancer	0.000524	0.00213	CcSEcCtD
Imipramine—ADRA1D—brain—brain cancer	0.000524	0.00232	CbGeAlD
Imipramine—Vomiting—Procarbazine—brain cancer	0.000523	0.00213	CcSEcCtD
Imipramine—Nortriptyline—CYP2C9—brain cancer	0.000523	0.136	CrCbGaD
Imipramine—SLC22A3—head—brain cancer	0.000521	0.00231	CbGeAlD
Imipramine—Flushing—Etoposide—brain cancer	0.00052	0.00211	CcSEcCtD
Imipramine—Cardiac disorder—Etoposide—brain cancer	0.00052	0.00211	CcSEcCtD
Imipramine—HTR1A—midbrain—brain cancer	0.000519	0.0023	CbGeAlD
Imipramine—Confusional state—Carmustine—brain cancer	0.000519	0.00211	CcSEcCtD
Imipramine—Rash—Procarbazine—brain cancer	0.000519	0.00211	CcSEcCtD
Imipramine—Dermatitis—Procarbazine—brain cancer	0.000519	0.00211	CcSEcCtD
Imipramine—Anxiety—Temozolomide—brain cancer	0.000517	0.0021	CcSEcCtD
Imipramine—HRH1—telencephalon—brain cancer	0.000516	0.00229	CbGeAlD
Imipramine—Headache—Procarbazine—brain cancer	0.000516	0.0021	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000516	0.0021	CcSEcCtD
Imipramine—Oedema—Carmustine—brain cancer	0.000515	0.00209	CcSEcCtD
Imipramine—SLC6A4—endocrine gland—brain cancer	0.000514	0.00228	CbGeAlD
Imipramine—Discomfort—Temozolomide—brain cancer	0.000513	0.00208	CcSEcCtD
Imipramine—CHRM1—endocrine gland—brain cancer	0.000512	0.00227	CbGeAlD
Imipramine—Infection—Carmustine—brain cancer	0.000512	0.00208	CcSEcCtD
Imipramine—SLC22A4—cerebellum—brain cancer	0.000511	0.00227	CbGeAlD
Imipramine—Angiopathy—Etoposide—brain cancer	0.000509	0.00207	CcSEcCtD
Imipramine—Dry mouth—Temozolomide—brain cancer	0.000508	0.00206	CcSEcCtD
Imipramine—SLC6A4—head—brain cancer	0.000507	0.00225	CbGeAlD
Imipramine—HTR1A—spinal cord—brain cancer	0.000507	0.00225	CbGeAlD
Imipramine—CHRM2—central nervous system—brain cancer	0.000507	0.00225	CbGeAlD
Imipramine—Immune system disorder—Etoposide—brain cancer	0.000506	0.00206	CcSEcCtD
Imipramine—KCNH2—medulla oblongata—brain cancer	0.000506	0.00224	CbGeAlD
Imipramine—CHRM1—head—brain cancer	0.000505	0.00224	CbGeAlD
Imipramine—SLC6A3—central nervous system—brain cancer	0.000505	0.00224	CbGeAlD
Imipramine—Mediastinal disorder—Etoposide—brain cancer	0.000505	0.00205	CcSEcCtD
Imipramine—Thrombocytopenia—Carmustine—brain cancer	0.000504	0.00205	CcSEcCtD
Imipramine—Body temperature increased—Hydroxyurea—brain cancer	0.000504	0.00205	CcSEcCtD
Imipramine—Tachycardia—Carmustine—brain cancer	0.000503	0.00204	CcSEcCtD
Imipramine—Confusional state—Temozolomide—brain cancer	0.000502	0.00204	CcSEcCtD
Imipramine—SLC22A1—central nervous system—brain cancer	0.000498	0.00221	CbGeAlD
Imipramine—Oedema—Temozolomide—brain cancer	0.000498	0.00202	CcSEcCtD
Imipramine—Anaphylactic shock—Temozolomide—brain cancer	0.000498	0.00202	CcSEcCtD
Imipramine—HTR7—midbrain—brain cancer	0.000496	0.0022	CbGeAlD
Imipramine—CYP2E1—telencephalon—brain cancer	0.000496	0.0022	CbGeAlD
Imipramine—Alopecia—Etoposide—brain cancer	0.000495	0.00201	CcSEcCtD
Imipramine—Infection—Temozolomide—brain cancer	0.000494	0.00201	CcSEcCtD
Imipramine—SLC6A3—cerebellum—brain cancer	0.000494	0.00219	CbGeAlD
Imipramine—Trimipramine—CYP2C9—brain cancer	0.000493	0.128	CrCbGaD
Imipramine—Anorexia—Carmustine—brain cancer	0.000491	0.002	CcSEcCtD
Imipramine—Nausea—Procarbazine—brain cancer	0.000489	0.00199	CcSEcCtD
Imipramine—HTR2C—central nervous system—brain cancer	0.000488	0.00217	CbGeAlD
Imipramine—Nervous system disorder—Temozolomide—brain cancer	0.000488	0.00198	CcSEcCtD
Imipramine—Thrombocytopenia—Temozolomide—brain cancer	0.000487	0.00198	CcSEcCtD
Imipramine—HTR2A—brainstem—brain cancer	0.000486	0.00215	CbGeAlD
Imipramine—HTR7—spinal cord—brain cancer	0.000484	0.00215	CbGeAlD
Imipramine—Diphenhydramine—CYP2C9—brain cancer	0.000484	0.125	CrCbGaD
Imipramine—Skin disorder—Temozolomide—brain cancer	0.000483	0.00196	CcSEcCtD
Imipramine—Hyperhidrosis—Temozolomide—brain cancer	0.000481	0.00196	CcSEcCtD
Imipramine—Dysgeusia—Etoposide—brain cancer	0.000478	0.00194	CcSEcCtD
Imipramine—SLC22A3—central nervous system—brain cancer	0.000476	0.00211	CbGeAlD
Imipramine—Anorexia—Temozolomide—brain cancer	0.000474	0.00193	CcSEcCtD
Imipramine—Promethazine—CYP2C9—brain cancer	0.000474	0.123	CrCbGaD
Imipramine—Doxepin—CYP2C9—brain cancer	0.00047	0.122	CrCbGaD
Imipramine—DRD2—midbrain—brain cancer	0.000469	0.00208	CbGeAlD
Imipramine—Insomnia—Carmustine—brain cancer	0.000466	0.00189	CcSEcCtD
Imipramine—SLC6A4—central nervous system—brain cancer	0.000463	0.00205	CbGeAlD
Imipramine—Paraesthesia—Carmustine—brain cancer	0.000462	0.00188	CcSEcCtD
Imipramine—KCNH2—midbrain—brain cancer	0.000462	0.00205	CbGeAlD
Imipramine—CHRM1—central nervous system—brain cancer	0.000461	0.00205	CbGeAlD
Imipramine—CHRM3—endocrine gland—brain cancer	0.000458	0.00203	CbGeAlD
Imipramine—Somnolence—Carmustine—brain cancer	0.000458	0.00186	CcSEcCtD
Imipramine—Asthenia—Hydroxyurea—brain cancer	0.000457	0.00186	CcSEcCtD
Imipramine—HTR1A—endocrine gland—brain cancer	0.000456	0.00202	CbGeAlD
Imipramine—Ill-defined disorder—Etoposide—brain cancer	0.000453	0.00184	CcSEcCtD
Imipramine—SLC6A2—endocrine gland—brain cancer	0.000452	0.00201	CbGeAlD
Imipramine—CHRM3—head—brain cancer	0.000452	0.00201	CbGeAlD
Imipramine—KCNH2—spinal cord—brain cancer	0.000451	0.002	CbGeAlD
Imipramine—HTR1A—head—brain cancer	0.00045	0.002	CbGeAlD
Imipramine—Insomnia—Temozolomide—brain cancer	0.00045	0.00183	CcSEcCtD
Imipramine—Decreased appetite—Carmustine—brain cancer	0.000448	0.00182	CcSEcCtD
Imipramine—Paraesthesia—Temozolomide—brain cancer	0.000447	0.00182	CcSEcCtD
Imipramine—SLC6A2—head—brain cancer	0.000447	0.00198	CbGeAlD
Imipramine—Gastrointestinal disorder—Carmustine—brain cancer	0.000445	0.00181	CcSEcCtD
Imipramine—Somnolence—Temozolomide—brain cancer	0.000442	0.0018	CcSEcCtD
Imipramine—CYP2D6—brainstem—brain cancer	0.000442	0.00196	CbGeAlD
Imipramine—CYP2B6—gonad—brain cancer	0.000441	0.00196	CbGeAlD
Imipramine—Constipation—Carmustine—brain cancer	0.00044	0.00179	CcSEcCtD
Imipramine—Malaise—Etoposide—brain cancer	0.00044	0.00179	CcSEcCtD
Imipramine—Dyspepsia—Temozolomide—brain cancer	0.000438	0.00178	CcSEcCtD
Imipramine—Leukopenia—Etoposide—brain cancer	0.000437	0.00178	CcSEcCtD
Imipramine—HTR7—endocrine gland—brain cancer	0.000436	0.00193	CbGeAlD
Imipramine—Diarrhoea—Hydroxyurea—brain cancer	0.000436	0.00177	CcSEcCtD
Imipramine—Decreased appetite—Temozolomide—brain cancer	0.000433	0.00176	CcSEcCtD
Imipramine—HTR2A—telencephalon—brain cancer	0.000431	0.00191	CbGeAlD
Imipramine—HTR7—head—brain cancer	0.00043	0.00191	CbGeAlD
Imipramine—Gastrointestinal disorder—Temozolomide—brain cancer	0.00043	0.00175	CcSEcCtD
Imipramine—Fatigue—Temozolomide—brain cancer	0.000429	0.00174	CcSEcCtD
Imipramine—Loss of consciousness—Etoposide—brain cancer	0.000429	0.00174	CcSEcCtD
Imipramine—CYP2C19—endocrine gland—brain cancer	0.000426	0.00189	CbGeAlD
Imipramine—Constipation—Temozolomide—brain cancer	0.000426	0.00173	CcSEcCtD
Imipramine—Feeling abnormal—Carmustine—brain cancer	0.000424	0.00172	CcSEcCtD
Imipramine—Convulsion—Etoposide—brain cancer	0.000423	0.00172	CcSEcCtD
Imipramine—Hypertension—Etoposide—brain cancer	0.000421	0.00171	CcSEcCtD
Imipramine—Dizziness—Hydroxyurea—brain cancer	0.000421	0.00171	CcSEcCtD
Imipramine—Gastrointestinal pain—Carmustine—brain cancer	0.000421	0.00171	CcSEcCtD
Imipramine—ADRA1A—endocrine gland—brain cancer	0.000421	0.00186	CbGeAlD
Imipramine—Promazine—CYP2C9—brain cancer	0.000417	0.108	CrCbGaD
Imipramine—ADRA1A—head—brain cancer	0.000415	0.00184	CbGeAlD
Imipramine—SLC22A4—brain—brain cancer	0.000415	0.00184	CbGeAlD
Imipramine—CHRM3—central nervous system—brain cancer	0.000413	0.00183	CbGeAlD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000413	0.00168	CcSEcCtD
Imipramine—DRD2—endocrine gland—brain cancer	0.000412	0.00183	CbGeAlD
Imipramine—HTR1A—central nervous system—brain cancer	0.000411	0.00182	CbGeAlD
Imipramine—Discomfort—Etoposide—brain cancer	0.00041	0.00167	CcSEcCtD
Imipramine—Feeling abnormal—Temozolomide—brain cancer	0.00041	0.00167	CcSEcCtD
Imipramine—SLC6A2—central nervous system—brain cancer	0.000408	0.00181	CbGeAlD
Imipramine—Body temperature increased—Carmustine—brain cancer	0.000407	0.00165	CcSEcCtD
Imipramine—Abdominal pain—Carmustine—brain cancer	0.000407	0.00165	CcSEcCtD
Imipramine—Gastrointestinal pain—Temozolomide—brain cancer	0.000407	0.00165	CcSEcCtD
Imipramine—DRD2—head—brain cancer	0.000407	0.0018	CbGeAlD
Imipramine—KCNH2—endocrine gland—brain cancer	0.000406	0.0018	CbGeAlD
Imipramine—Vomiting—Hydroxyurea—brain cancer	0.000405	0.00165	CcSEcCtD
Imipramine—CHRM2—brain—brain cancer	0.000402	0.00178	CbGeAlD
Imipramine—HTR1A—cerebellum—brain cancer	0.000402	0.00178	CbGeAlD
Imipramine—Rash—Hydroxyurea—brain cancer	0.000402	0.00163	CcSEcCtD
Imipramine—Confusional state—Etoposide—brain cancer	0.000402	0.00163	CcSEcCtD
Imipramine—Dermatitis—Hydroxyurea—brain cancer	0.000401	0.00163	CcSEcCtD
Imipramine—SLC6A3—brain—brain cancer	0.000401	0.00178	CbGeAlD
Imipramine—KCNH2—head—brain cancer	0.000401	0.00178	CbGeAlD
Imipramine—Headache—Hydroxyurea—brain cancer	0.000399	0.00162	CcSEcCtD
Imipramine—Anaphylactic shock—Etoposide—brain cancer	0.000398	0.00162	CcSEcCtD
Imipramine—Infection—Etoposide—brain cancer	0.000396	0.00161	CcSEcCtD
Imipramine—Urticaria—Temozolomide—brain cancer	0.000395	0.00161	CcSEcCtD
Imipramine—SLC22A1—brain—brain cancer	0.000395	0.00175	CbGeAlD
Imipramine—Body temperature increased—Temozolomide—brain cancer	0.000393	0.0016	CcSEcCtD
Imipramine—Abdominal pain—Temozolomide—brain cancer	0.000393	0.0016	CcSEcCtD
Imipramine—HTR7—central nervous system—brain cancer	0.000393	0.00174	CbGeAlD
Imipramine—CYP2D6—telencephalon—brain cancer	0.000393	0.00174	CbGeAlD
Imipramine—Thrombocytopenia—Etoposide—brain cancer	0.00039	0.00158	CcSEcCtD
Imipramine—CYP2E1—medulla oblongata—brain cancer	0.00039	0.00173	CbGeAlD
Imipramine—Tachycardia—Etoposide—brain cancer	0.000389	0.00158	CcSEcCtD
Imipramine—HTR2C—brain—brain cancer	0.000388	0.00172	CbGeAlD
Imipramine—Skin disorder—Etoposide—brain cancer	0.000387	0.00157	CcSEcCtD
Imipramine—Hyperhidrosis—Etoposide—brain cancer	0.000385	0.00156	CcSEcCtD
Imipramine—HTR7—cerebellum—brain cancer	0.000384	0.0017	CbGeAlD
Imipramine—Anorexia—Etoposide—brain cancer	0.00038	0.00154	CcSEcCtD
Imipramine—ADRA1A—central nervous system—brain cancer	0.000379	0.00168	CbGeAlD
Imipramine—Nausea—Hydroxyurea—brain cancer	0.000378	0.00154	CcSEcCtD
Imipramine—SLC22A3—brain—brain cancer	0.000378	0.00167	CbGeAlD
Imipramine—DRD2—central nervous system—brain cancer	0.000371	0.00165	CbGeAlD
Imipramine—ADRA1A—cerebellum—brain cancer	0.00037	0.00164	CbGeAlD
Imipramine—Asthenia—Carmustine—brain cancer	0.00037	0.0015	CcSEcCtD
Imipramine—SLC6A4—brain—brain cancer	0.000368	0.00163	CbGeAlD
Imipramine—CHRM1—brain—brain cancer	0.000366	0.00162	CbGeAlD
Imipramine—KCNH2—central nervous system—brain cancer	0.000366	0.00162	CbGeAlD
Imipramine—Amitriptyline—CYP2C9—brain cancer	0.000363	0.0941	CrCbGaD
Imipramine—DRD2—cerebellum—brain cancer	0.000363	0.00161	CbGeAlD
Imipramine—HTR2A—gonad—brain cancer	0.00036	0.0016	CbGeAlD
Imipramine—KCNH2—cerebellum—brain cancer	0.000358	0.00159	CbGeAlD
Imipramine—Paraesthesia—Etoposide—brain cancer	0.000358	0.00145	CcSEcCtD
Imipramine—Asthenia—Temozolomide—brain cancer	0.000357	0.00145	CcSEcCtD
Imipramine—Somnolence—Etoposide—brain cancer	0.000354	0.00144	CcSEcCtD
Imipramine—Diarrhoea—Carmustine—brain cancer	0.000352	0.00143	CcSEcCtD
Imipramine—Pruritus—Temozolomide—brain cancer	0.000352	0.00143	CcSEcCtD
Imipramine—HTR2A—pituitary gland—brain cancer	0.000351	0.00156	CbGeAlD
Imipramine—CYP1A2—endocrine gland—brain cancer	0.000348	0.00154	CbGeAlD
Imipramine—CYP2E1—spinal cord—brain cancer	0.000347	0.00154	CbGeAlD
Imipramine—Decreased appetite—Etoposide—brain cancer	0.000346	0.00141	CcSEcCtD
Imipramine—Gastrointestinal disorder—Etoposide—brain cancer	0.000344	0.0014	CcSEcCtD
Imipramine—Fatigue—Etoposide—brain cancer	0.000343	0.0014	CcSEcCtD
Imipramine—Dizziness—Carmustine—brain cancer	0.000341	0.00138	CcSEcCtD
Imipramine—Constipation—Etoposide—brain cancer	0.000341	0.00138	CcSEcCtD
Imipramine—Diarrhoea—Temozolomide—brain cancer	0.000341	0.00138	CcSEcCtD
Imipramine—HTR2A—medulla oblongata—brain cancer	0.000339	0.0015	CbGeAlD
Imipramine—CYP2B6—endocrine gland—brain cancer	0.000333	0.00148	CbGeAlD
Imipramine—Dizziness—Temozolomide—brain cancer	0.000329	0.00134	CcSEcCtD
Imipramine—CYP2B6—head—brain cancer	0.000329	0.00146	CbGeAlD
Imipramine—Feeling abnormal—Etoposide—brain cancer	0.000328	0.00133	CcSEcCtD
Imipramine—CHRM3—brain—brain cancer	0.000328	0.00145	CbGeAlD
Imipramine—Vomiting—Carmustine—brain cancer	0.000327	0.00133	CcSEcCtD
Imipramine—HTR1A—brain—brain cancer	0.000326	0.00145	CbGeAlD
Imipramine—Gastrointestinal pain—Etoposide—brain cancer	0.000326	0.00132	CcSEcCtD
Imipramine—HRH1—endocrine gland—brain cancer	0.000326	0.00144	CbGeAlD
Imipramine—Rash—Carmustine—brain cancer	0.000325	0.00132	CcSEcCtD
Imipramine—Dermatitis—Carmustine—brain cancer	0.000324	0.00132	CcSEcCtD
Imipramine—SLC6A2—brain—brain cancer	0.000324	0.00144	CbGeAlD
Imipramine—Headache—Carmustine—brain cancer	0.000323	0.00131	CcSEcCtD
Imipramine—HRH1—head—brain cancer	0.000321	0.00143	CbGeAlD
Imipramine—Vomiting—Temozolomide—brain cancer	0.000316	0.00129	CcSEcCtD
Imipramine—Urticaria—Etoposide—brain cancer	0.000316	0.00129	CcSEcCtD
Imipramine—Abdominal pain—Etoposide—brain cancer	0.000315	0.00128	CcSEcCtD
Imipramine—Body temperature increased—Etoposide—brain cancer	0.000315	0.00128	CcSEcCtD
Imipramine—Rash—Temozolomide—brain cancer	0.000314	0.00128	CcSEcCtD
Imipramine—Dermatitis—Temozolomide—brain cancer	0.000314	0.00127	CcSEcCtD
Imipramine—CYP2E1—endocrine gland—brain cancer	0.000313	0.00139	CbGeAlD
Imipramine—HTR7—brain—brain cancer	0.000312	0.00138	CbGeAlD
Imipramine—Headache—Temozolomide—brain cancer	0.000312	0.00127	CcSEcCtD
Imipramine—HTR2A—midbrain—brain cancer	0.00031	0.00137	CbGeAlD
Imipramine—CYP2E1—head—brain cancer	0.000309	0.00137	CbGeAlD
Imipramine—Nausea—Carmustine—brain cancer	0.000306	0.00124	CcSEcCtD
Imipramine—HTR2A—spinal cord—brain cancer	0.000302	0.00134	CbGeAlD
Imipramine—ADRA1A—brain—brain cancer	0.000301	0.00133	CbGeAlD
Imipramine—CYP2B6—central nervous system—brain cancer	0.0003	0.00133	CbGeAlD
Imipramine—Nausea—Temozolomide—brain cancer	0.000296	0.0012	CcSEcCtD
Imipramine—DRD2—brain—brain cancer	0.000295	0.00131	CbGeAlD
Imipramine—HRH1—central nervous system—brain cancer	0.000293	0.0013	CbGeAlD
Imipramine—KCNH2—brain—brain cancer	0.000291	0.00129	CbGeAlD
Imipramine—Asthenia—Etoposide—brain cancer	0.000286	0.00116	CcSEcCtD
Imipramine—ABCB1—telencephalon—brain cancer	0.000282	0.00125	CbGeAlD
Imipramine—CYP2E1—central nervous system—brain cancer	0.000282	0.00125	CbGeAlD
Imipramine—Pruritus—Etoposide—brain cancer	0.000282	0.00115	CcSEcCtD
Imipramine—CYP2E1—cerebellum—brain cancer	0.000276	0.00122	CbGeAlD
Imipramine—Diarrhoea—Etoposide—brain cancer	0.000273	0.00111	CcSEcCtD
Imipramine—HTR2A—endocrine gland—brain cancer	0.000272	0.00121	CbGeAlD
Imipramine—HTR2A—head—brain cancer	0.000268	0.00119	CbGeAlD
Imipramine—Dizziness—Etoposide—brain cancer	0.000263	0.00107	CcSEcCtD
Imipramine—Vomiting—Etoposide—brain cancer	0.000253	0.00103	CcSEcCtD
Imipramine—CYP3A4—endocrine gland—brain cancer	0.000252	0.00112	CbGeAlD
Imipramine—Rash—Etoposide—brain cancer	0.000251	0.00102	CcSEcCtD
Imipramine—Dermatitis—Etoposide—brain cancer	0.000251	0.00102	CcSEcCtD
Imipramine—Headache—Etoposide—brain cancer	0.00025	0.00101	CcSEcCtD
Imipramine—CYP2D6—endocrine gland—brain cancer	0.000248	0.0011	CbGeAlD
Imipramine—HTR2A—central nervous system—brain cancer	0.000245	0.00109	CbGeAlD
Imipramine—CYP2D6—head—brain cancer	0.000245	0.00108	CbGeAlD
Imipramine—HTR2A—cerebellum—brain cancer	0.000239	0.00106	CbGeAlD
Imipramine—CYP2B6—brain—brain cancer	0.000238	0.00106	CbGeAlD
Imipramine—Nausea—Etoposide—brain cancer	0.000237	0.000961	CcSEcCtD
Imipramine—ABCB1—gonad—brain cancer	0.000236	0.00105	CbGeAlD
Imipramine—HRH1—brain—brain cancer	0.000233	0.00103	CbGeAlD
Imipramine—ABCB1—pituitary gland—brain cancer	0.00023	0.00102	CbGeAlD
Imipramine—CYP3A4—central nervous system—brain cancer	0.000227	0.00101	CbGeAlD
Imipramine—CYP2E1—brain—brain cancer	0.000224	0.000992	CbGeAlD
Imipramine—CYP2D6—central nervous system—brain cancer	0.000223	0.00099	CbGeAlD
Imipramine—ABCB1—medulla oblongata—brain cancer	0.000222	0.000984	CbGeAlD
Imipramine—CYP2D6—cerebellum—brain cancer	0.000218	0.000967	CbGeAlD
Imipramine—ABCB1—midbrain—brain cancer	0.000203	0.0009	CbGeAlD
Imipramine—ABCB1—spinal cord—brain cancer	0.000198	0.000878	CbGeAlD
Imipramine—HTR2A—brain—brain cancer	0.000195	0.000863	CbGeAlD
Imipramine—ABCB1—endocrine gland—brain cancer	0.000178	0.00079	CbGeAlD
Imipramine—CYP2D6—brain—brain cancer	0.000177	0.000786	CbGeAlD
Imipramine—ABCB1—head—brain cancer	0.000176	0.00078	CbGeAlD
Imipramine—ABCB1—central nervous system—brain cancer	0.000161	0.000712	CbGeAlD
Imipramine—ABCB1—cerebellum—brain cancer	0.000157	0.000696	CbGeAlD
Imipramine—ABCB1—brain—brain cancer	0.000127	0.000565	CbGeAlD
Imipramine—CHRM5—Signaling Pathways—APC—brain cancer	1.42e-05	0.000109	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—SPP1—brain cancer	1.38e-05	0.000106	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—PIK3CG—brain cancer	1.38e-05	0.000106	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—IL2—brain cancer	1.38e-05	0.000106	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—PIK3CG—brain cancer	1.38e-05	0.000106	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—HES1—brain cancer	1.38e-05	0.000106	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—IL2—brain cancer	1.38e-05	0.000106	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—HES1—brain cancer	1.36e-05	0.000104	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—HES1—brain cancer	1.36e-05	0.000104	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.35e-05	0.000104	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—HES1—brain cancer	1.35e-05	0.000104	CbGpPWpGaD
Imipramine—CHRM4—Signaling by GPCR—EGFR—brain cancer	1.35e-05	0.000104	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—HES1—brain cancer	1.35e-05	0.000104	CbGpPWpGaD
Imipramine—DRD2—GPCR downstream signaling—IL2—brain cancer	1.34e-05	0.000103	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—HES1—brain cancer	1.33e-05	0.000103	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—PIK3CG—brain cancer	1.33e-05	0.000102	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—APC—brain cancer	1.33e-05	0.000102	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—HES1—brain cancer	1.33e-05	0.000102	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—IL2—brain cancer	1.32e-05	0.000101	CbGpPWpGaD
Imipramine—HTR2A—GPCR downstream signaling—IL2—brain cancer	1.32e-05	0.000101	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—PDGFRA—brain cancer	1.31e-05	0.000101	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—IRS2—brain cancer	1.31e-05	0.000101	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—ENO2—brain cancer	1.31e-05	0.000101	CbGpPWpGaD
Imipramine—HRH1—GPCR downstream signaling—IL2—brain cancer	1.31e-05	0.000101	CbGpPWpGaD
Imipramine—CHRM1—GPCR downstream signaling—IL2—brain cancer	1.31e-05	0.000101	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—IRS2—brain cancer	1.31e-05	0.000101	CbGpPWpGaD
Imipramine—CHRM3—GPCR downstream signaling—IL2—brain cancer	1.3e-05	0.0001	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—PDGFRA—brain cancer	1.29e-05	9.94e-05	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—IL2—brain cancer	1.29e-05	9.93e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—EGFR—brain cancer	1.29e-05	9.92e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—PDGFRA—brain cancer	1.29e-05	9.92e-05	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—IL2—brain cancer	1.29e-05	9.9e-05	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—PIK3CG—brain cancer	1.29e-05	9.9e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—PDGFRA—brain cancer	1.29e-05	9.89e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—PDGFRA—brain cancer	1.28e-05	9.86e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—IDH1—brain cancer	1.28e-05	9.85e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—SPP1—brain cancer	1.28e-05	9.81e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—PDGFRA—brain cancer	1.27e-05	9.76e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—PDGFRA—brain cancer	1.27e-05	9.73e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—SPP1—brain cancer	1.26e-05	9.65e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—SPP1—brain cancer	1.25e-05	9.63e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—IRS2—brain cancer	1.25e-05	9.62e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—SPP1—brain cancer	1.25e-05	9.6e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—SPP1—brain cancer	1.24e-05	9.57e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—SPP1—brain cancer	1.23e-05	9.48e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—SPP1—brain cancer	1.23e-05	9.45e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—RELA—brain cancer	1.23e-05	9.42e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—RELA—brain cancer	1.22e-05	9.41e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—ERBB2—brain cancer	1.22e-05	9.36e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—ERBB2—brain cancer	1.22e-05	9.35e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—IL2—brain cancer	1.21e-05	9.33e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—EGFR—brain cancer	1.21e-05	9.33e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—IL2—brain cancer	1.19e-05	9.18e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—IL2—brain cancer	1.19e-05	9.16e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—PIK3CG—brain cancer	1.19e-05	9.14e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—IL2—brain cancer	1.19e-05	9.13e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—IL2—brain cancer	1.18e-05	9.1e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—IL2—brain cancer	1.17e-05	9.02e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—IL2—brain cancer	1.17e-05	8.99e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—PIK3CG—brain cancer	1.16e-05	8.92e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—APC—brain cancer	1.16e-05	8.92e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—RELA—brain cancer	1.16e-05	8.89e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—PIK3CG—brain cancer	1.15e-05	8.88e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—APC—brain cancer	1.15e-05	8.88e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—IRS2—brain cancer	1.15e-05	8.87e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—ERBB2—brain cancer	1.15e-05	8.83e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—IRS2—brain cancer	1.14e-05	8.73e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—IRS2—brain cancer	1.13e-05	8.71e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—IRS2—brain cancer	1.13e-05	8.68e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—IRS2—brain cancer	1.13e-05	8.65e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—IRS2—brain cancer	1.11e-05	8.57e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—IRS2—brain cancer	1.11e-05	8.55e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—RELA—brain cancer	1.11e-05	8.51e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—APC—brain cancer	1.11e-05	8.5e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—PIK3CG—brain cancer	1.11e-05	8.5e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—IL2—brain cancer	1.1e-05	8.48e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—IL2—brain cancer	1.1e-05	8.47e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—ERBB2—brain cancer	1.1e-05	8.46e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—CCND1—brain cancer	1.08e-05	8.27e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—CCND1—brain cancer	1.07e-05	8.26e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—CTNNB1—brain cancer	1.07e-05	8.19e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—CTNNB1—brain cancer	1.06e-05	8.18e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—EGFR—brain cancer	1.06e-05	8.13e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—EGFR—brain cancer	1.05e-05	8.09e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—IL2—brain cancer	1.04e-05	8e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—RELA—brain cancer	1.04e-05	8e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—ERBB2—brain cancer	1.03e-05	7.95e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—PIK3CG—brain cancer	1.02e-05	7.86e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—APC—brain cancer	1.02e-05	7.83e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—PIK3CG—brain cancer	1.02e-05	7.83e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—CCND1—brain cancer	1.01e-05	7.8e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ENO2—brain cancer	1.01e-05	7.79e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—EGFR—brain cancer	1.01e-05	7.74e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—CTNNB1—brain cancer	1.01e-05	7.72e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—PIK3CG—brain cancer	1e-05	7.71e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—APC—brain cancer	1e-05	7.71e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—PIK3CG—brain cancer	1e-05	7.7e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—APC—brain cancer	1e-05	7.69e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—PIK3CG—brain cancer	1e-05	7.69e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—APC—brain cancer	9.98e-06	7.67e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—PIK3CG—brain cancer	9.98e-06	7.67e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—IL2—brain cancer	9.97e-06	7.66e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—APC—brain cancer	9.94e-06	7.64e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—PIK3CG—brain cancer	9.94e-06	7.64e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—APC—brain cancer	9.85e-06	7.57e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—PIK3CG—brain cancer	9.85e-06	7.57e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—PIK3CG—brain cancer	9.82e-06	7.55e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—APC—brain cancer	9.82e-06	7.55e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—CCND1—brain cancer	9.72e-06	7.47e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—CTNNB1—brain cancer	9.62e-06	7.4e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—VEGFA—brain cancer	9.38e-06	7.21e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—IL2—brain cancer	9.37e-06	7.2e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—VEGFA—brain cancer	9.37e-06	7.2e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—STAT3—brain cancer	9.29e-06	7.14e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—EGFR—brain cancer	9.29e-06	7.14e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—STAT3—brain cancer	9.28e-06	7.13e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—CCND1—brain cancer	9.14e-06	7.02e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—EGFR—brain cancer	9.14e-06	7.02e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—EGFR—brain cancer	9.12e-06	7.01e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—EGFR—brain cancer	9.09e-06	6.99e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—RELA—brain cancer	9.07e-06	6.97e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—EGFR—brain cancer	9.06e-06	6.96e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—CTNNB1—brain cancer	9.05e-06	6.96e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—RELA—brain cancer	9.02e-06	6.94e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—ERBB2—brain cancer	9.01e-06	6.93e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—EGFR—brain cancer	8.97e-06	6.9e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—ERBB2—brain cancer	8.97e-06	6.89e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—EGFR—brain cancer	8.95e-06	6.88e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—VEGFA—brain cancer	8.85e-06	6.8e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—STAT3—brain cancer	8.76e-06	6.73e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—RELA—brain cancer	8.64e-06	6.64e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—MYC—brain cancer	8.63e-06	6.63e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—MYC—brain cancer	8.62e-06	6.63e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—ERBB2—brain cancer	8.58e-06	6.6e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—VEGFA—brain cancer	8.47e-06	6.51e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—EGFR—brain cancer	8.44e-06	6.49e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—EGFR—brain cancer	8.43e-06	6.48e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—STAT3—brain cancer	8.39e-06	6.45e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—IL2—brain cancer	8.17e-06	6.28e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—MYC—brain cancer	8.14e-06	6.26e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—IL2—brain cancer	8.13e-06	6.25e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—VEGFA—brain cancer	7.97e-06	6.12e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—RELA—brain cancer	7.96e-06	6.12e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CCND1—brain cancer	7.96e-06	6.12e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—EGFR—brain cancer	7.96e-06	6.12e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CCND1—brain cancer	7.92e-06	6.09e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—ERBB2—brain cancer	7.91e-06	6.08e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—STAT3—brain cancer	7.89e-06	6.06e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CTNNB1—brain cancer	7.89e-06	6.06e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CTNNB1—brain cancer	7.85e-06	6.03e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—RELA—brain cancer	7.84e-06	6.02e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—RELA—brain cancer	7.82e-06	6.01e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—MYC—brain cancer	7.8e-06	5.99e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—RELA—brain cancer	7.79e-06	5.99e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—ERBB2—brain cancer	7.79e-06	5.99e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—IL2—brain cancer	7.78e-06	5.98e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—ERBB2—brain cancer	7.77e-06	5.97e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—RELA—brain cancer	7.77e-06	5.97e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—ERBB2—brain cancer	7.75e-06	5.95e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PIK3CG—brain cancer	7.73e-06	5.94e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—ERBB2—brain cancer	7.72e-06	5.93e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—RELA—brain cancer	7.69e-06	5.91e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—RELA—brain cancer	7.67e-06	5.9e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—ERBB2—brain cancer	7.65e-06	5.88e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—EGFR—brain cancer	7.62e-06	5.86e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—ERBB2—brain cancer	7.62e-06	5.86e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CCND1—brain cancer	7.58e-06	5.83e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PIK3CG—brain cancer	7.55e-06	5.8e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CTNNB1—brain cancer	7.51e-06	5.77e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—MYC—brain cancer	7.33e-06	5.63e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—IL2—brain cancer	7.17e-06	5.51e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—EGFR—brain cancer	7.17e-06	5.51e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PIK3CG—brain cancer	7.11e-06	5.47e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—TP53—brain cancer	7.09e-06	5.45e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—TP53—brain cancer	7.08e-06	5.44e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—IL2—brain cancer	7.06e-06	5.42e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—IL2—brain cancer	7.04e-06	5.41e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—IL2—brain cancer	7.02e-06	5.4e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—IL2—brain cancer	7e-06	5.38e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CCND1—brain cancer	6.99e-06	5.37e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—VEGFA—brain cancer	6.94e-06	5.34e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—IL2—brain cancer	6.93e-06	5.33e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CTNNB1—brain cancer	6.92e-06	5.32e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—IL2—brain cancer	6.91e-06	5.31e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—VEGFA—brain cancer	6.91e-06	5.31e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CCND1—brain cancer	6.88e-06	5.29e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—STAT3—brain cancer	6.87e-06	5.28e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CCND1—brain cancer	6.87e-06	5.28e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CCND1—brain cancer	6.84e-06	5.26e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—STAT3—brain cancer	6.84e-06	5.26e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CCND1—brain cancer	6.82e-06	5.24e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CTNNB1—brain cancer	6.81e-06	5.24e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CTNNB1—brain cancer	6.8e-06	5.23e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CTNNB1—brain cancer	6.78e-06	5.21e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CCND1—brain cancer	6.76e-06	5.19e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CTNNB1—brain cancer	6.76e-06	5.19e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CCND1—brain cancer	6.74e-06	5.18e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CTNNB1—brain cancer	6.69e-06	5.14e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—TP53—brain cancer	6.69e-06	5.14e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CTNNB1—brain cancer	6.67e-06	5.13e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—VEGFA—brain cancer	6.61e-06	5.08e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—STAT3—brain cancer	6.55e-06	5.03e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—TP53—brain cancer	6.4e-06	4.92e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—MYC—brain cancer	6.39e-06	4.91e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—MYC—brain cancer	6.35e-06	4.88e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—EGFR—brain cancer	6.25e-06	4.8e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—EGFR—brain cancer	6.22e-06	4.78e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—VEGFA—brain cancer	6.1e-06	4.69e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—MYC—brain cancer	6.08e-06	4.68e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—STAT3—brain cancer	6.04e-06	4.64e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PIK3CG—brain cancer	6.02e-06	4.63e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—TP53—brain cancer	6.02e-06	4.63e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—VEGFA—brain cancer	6e-06	4.61e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—VEGFA—brain cancer	5.98e-06	4.6e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—VEGFA—brain cancer	5.97e-06	4.59e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—EGFR—brain cancer	5.95e-06	4.57e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—VEGFA—brain cancer	5.95e-06	4.57e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—STAT3—brain cancer	5.94e-06	4.56e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—STAT3—brain cancer	5.93e-06	4.55e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—STAT3—brain cancer	5.91e-06	4.54e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—VEGFA—brain cancer	5.89e-06	4.53e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—STAT3—brain cancer	5.89e-06	4.53e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—VEGFA—brain cancer	5.87e-06	4.51e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—STAT3—brain cancer	5.83e-06	4.48e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—STAT3—brain cancer	5.82e-06	4.47e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—MYC—brain cancer	5.61e-06	4.31e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—MYC—brain cancer	5.52e-06	4.24e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—MYC—brain cancer	5.51e-06	4.23e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—MYC—brain cancer	5.49e-06	4.22e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—EGFR—brain cancer	5.49e-06	4.22e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—MYC—brain cancer	5.47e-06	4.21e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—MYC—brain cancer	5.42e-06	4.16e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—MYC—brain cancer	5.4e-06	4.15e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—EGFR—brain cancer	5.4e-06	4.15e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—EGFR—brain cancer	5.39e-06	4.14e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—EGFR—brain cancer	5.37e-06	4.13e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—EGFR—brain cancer	5.35e-06	4.11e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—EGFR—brain cancer	5.3e-06	4.07e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—EGFR—brain cancer	5.29e-06	4.06e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—TP53—brain cancer	5.25e-06	4.03e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—TP53—brain cancer	5.22e-06	4.01e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—TP53—brain cancer	5e-06	3.84e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PIK3CG—brain cancer	4.65e-06	3.57e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—TP53—brain cancer	4.61e-06	3.54e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—TP53—brain cancer	4.53e-06	3.48e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—TP53—brain cancer	4.52e-06	3.48e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—TP53—brain cancer	4.51e-06	3.46e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—TP53—brain cancer	4.49e-06	3.45e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—TP53—brain cancer	4.45e-06	3.42e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—TP53—brain cancer	4.44e-06	3.41e-05	CbGpPWpGaD
